Filter Results :

Your search for Antibodies returned 55 reports

Sort by


Global Monoclonal Antibodies Pipeline Insight 2015

04 Mar 2015  |  Published by:  PNS Pharma
Ever since the Nobel Prize was bestowed on the person who invented the technology which enabled the preparation of monoclonal antibodies in 1984, their use has considerably expanded far beyond the scientific realm. Paul Ehrlich framed a hypothesis that a “magic bullet” could be developed with ...

$ 2,400.00

Read More

Competitor Analysis: Specific and Bispecific Her3 Antibodies

16 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Specific and Bispecific Her3 Antibodies provides a competitor evaluation in the field of recombinant specific antibodies targeting Her3 or bispecific antibodies targeting Her3 and Her2 or EGF-R or other targets for treatment of cancer as of February 2...

$ 222.71

Read More

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

15 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the field of recombinant antibodies targeting Her2 for treatment of Her2 positive breast and gastric cancer as of February 2015. Purchase of the downl...

$ 334.07

Read More

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis

08 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis provides a competitor evaluation in the field of recombinant antibodies targeting vascular endothelial growth factor (VEGF) or its receptors (VEGF-R) used to treat ...

$ 389.75

Read More

Global Markets for Research Antibodies

01 Jan 2015  |  Published by:  BCC Research
The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019. This report provides:-An overview of the globa...

$ 6,650.00

Read More

Scantibodies Laboratory, Inc. - Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryScantibodies Laboratory, Inc. (Scantibodies) is a biotechnology company. The company develops and manufactures medical tests and their critical components. Its products include polyclonal antibodies, monoclonal antibodies additives, heterophilic blocking reagent, redicon liquid controls, sysc...

$ 300.00

Read More

Fusion Antibodies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

18 Nov 2014  |  Published by:  GlobalData
SummaryFusion Antibodies Ltd (Fusion Antibodies) is a contract research organization (CRO). It holds expertise and offers contract services in the production of monoclonal antibodies, antibody sequencing, antibody engineering and humanization, and antibody expression. The organization offers a wide ...

$ 250.00

Read More

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

03 Nov 2014  |  Published by:  MarketsandMarkets
Report Description Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The mono...

$ 4,650.00

Read More

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

03 Oct 2014  |  Published by:  KuicK Research
Recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers have increased their learning about the human body’s immune system, which has led to ...

$ 2,400.00

Read More

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

21 Sep 2014  |  Published by:  La Merie Business Intelligence
The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competitor evaluation in the field of marketed and new molecules for prevention or treatment of Rabies virus infections as of September 2014. Purchase of the downloadable pdf report ...

$ 222.71

Read More

Monoclonal Antibodies Partnering Terms and Agreements

01 Aug 2014  |  Published by:  CurrentPartnering
The report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deal...

$ 2,995.00

Read More

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014

12 Mar 2014  |  Published by:  La Merie Business Intelligence
The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of...

$ 1,224.93

Read More

Competitor Analysis: EGF-R Antibodies - Biosimilars and Biosuperiors

04 Mar 2014  |  Published by:  La Merie Business Intelligence
The present Competitive Intelligence Report about EGF-R Antibodies –Biosimilars and Biosuperiors provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2014. Purchase of the downloadable pdf ...

$ 278.39

Read More

2013 Sales of Recombinant Therapeutic Antibodies & Proteins

01 Mar 2014  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2013. Sales data were obtained from company publications and refer to branded products originating fr...

$ 55.68

Read More

Competitor Analysis: TNF Antibodies - Biosimilars and Biosuperiors

28 Feb 2014  |  Published by:  La Merie Business Intelligence
The present Competitive Intelligence Report about TNF Antibodies –Biosimilars and Biosuperiors provides a competitor evaluation in the field of recombinant antibodies targeting tumor necrosis factor (TNF) alpha or its receptor used to treat various inflammatory and autoimmune diseases as of Ma...

$ 445.43

Read More
Total 55 records.